Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammasome biology, molecular pathology and therapeutic implications
Fawaz Awad, Eman Assrawi, Camille Louvrier, et al.
Pharmacology & Therapeutics (2018) Vol. 187, pp. 133-149
Closed Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang Yang, Huanan Wang, Mohammed Kouadir, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 2
Open Access | Times Cited: 1063
Interleukin-1 Beta—A Friend or Foe in Malignancies?
Rebekka Bent, Lorna Moll, Stephan Grabbe, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2155-2155
Open Access | Times Cited: 362
Systemic autoinflammatory diseases
Julie Krainer, Sandra Siebenhandl, Andreas Weinhäusel
Journal of Autoimmunity (2020) Vol. 109, pp. 102421-102421
Open Access | Times Cited: 157
hucMSC-derived exosomes attenuate colitis by regulating macrophage pyroptosis via the miR-378a-5p/NLRP3 axis
Xiu Jun Cai, Zhiyu Zhang, Jintao Yuan, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 106
Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome
Hao Li, Yanling Guan, Bo Liang, et al.
European Journal of Pharmacology (2022) Vol. 928, pp. 175091-175091
Closed Access | Times Cited: 106
Dual-engineered cartilage-targeting extracellular vesicles derived from mesenchymal stem cells enhance osteoarthritis treatment via miR-223/NLRP3/pyroptosis axis: Toward a precision therapy
Weixuan Liu, Anqi Liu, Xujun Li, et al.
Bioactive Materials (2023) Vol. 30, pp. 169-183
Open Access | Times Cited: 49
E2-Induced Activation of the NLRP3 Inflammasome Triggers Pyroptosis and Inhibits Autophagy in HCC Cells
Qing Wei, Rui Zhu, Junying Zhu, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2019) Vol. 27, Iss. 7, pp. 827-834
Open Access | Times Cited: 145
The pathological role of NLRs and AIM2 inflammasome-mediated pyroptosis in damaged blood-brain barrier after traumatic brain injury
Xintong Ge, Wenzhu Li, Shan Huang, et al.
Brain Research (2018) Vol. 1697, pp. 10-20
Closed Access | Times Cited: 125
Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review
Danbin Wu, Yefei Chen, Yingxin Sun, et al.
Inflammation (2019) Vol. 43, Iss. 1, pp. 17-23
Closed Access | Times Cited: 125
Immunomodulation by Helminths: Intracellular Pathways and Extracellular Vesicles
Amin Zakeri, Eline Palm Hansen, Sidsel Dahl Andersen, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 116
Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases
Xiangna Zhang, Ana Xu, Jiahui Lv, et al.
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111822-111822
Closed Access | Times Cited: 116
ER Stress Activates the NLRP3 Inflammasome: A Novel Mechanism of Atherosclerosis
Xinnong Chen, Xiao-chen Guo, Qihui Ge, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-18
Open Access | Times Cited: 103
Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
Bo‐Zong Shao, Qi Cao, Liu Chong
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 95
Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation
Bo‐Zong Shao, Shuling Wang, Peng Pan, et al.
Inflammation (2019) Vol. 42, Iss. 4, pp. 1147-1159
Closed Access | Times Cited: 92
Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome
Lei Hou, Le Yang, Na Chang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 88
VX765 Attenuates Pyroptosis and HMGB1/TLR4/NF-κB Pathways to Improve Functional Outcomes in TBI Mice
Zhezhe Sun, Mark Nyanzu, Su Yang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-21
Open Access | Times Cited: 86
Therapeutic potential of ginger against COVID-19: Is there enough evidence?
Abdollah Jafarzadeh, Sara Jafarzadeh, Maryam Nemati
Journal of Traditional Chinese Medical Sciences (2021) Vol. 8, Iss. 4, pp. 267-279
Open Access | Times Cited: 74
Inflammasome and Mitophagy Connection in Health and Disease
Jae‐Min Yuk, Prashanta Silwal, Eun‐Kyeong Jo
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4714-4714
Open Access | Times Cited: 72
Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics
Yueran Cui, Haiyang Yu, Zhongqi Bu, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 43
Inflammatory Mediators of Endothelial Dysfunction
Eirini Dri, Evangelos Lampas, George Lazaros, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1420-1420
Open Access | Times Cited: 42
The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases
Saverio La Bella, Armando Di Ludovico, Giulia Di Donato, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 10
Mechanism of NLRP3 Inflammasome in Epilepsy and Related Therapeutic Agents
Juan Chen, Yuan Gao, Ning Liu, et al.
Neuroscience (2024) Vol. 546, pp. 157-177
Closed Access | Times Cited: 10
Astragaloside IV Suppresses High Glucose-Induced NLRP3 Inflammasome Activation by Inhibiting TLR4/NF-κB and CaSR
Bin Leng, Yingjie Zhang, Xinran Liu, et al.
Mediators of Inflammation (2019) Vol. 2019, pp. 1-16
Open Access | Times Cited: 71
Therapeutic potentials of ginger for treatment of Multiple sclerosis: A review with emphasis on its immunomodulatory, anti-inflammatory and anti-oxidative properties
Abdollah Jafarzadeh, Maryam Nemati
Journal of Neuroimmunology (2018) Vol. 324, pp. 54-75
Closed Access | Times Cited: 70
Gastrodin ameliorates microvascular reperfusion injury–induced pyroptosis by regulating the NLRP3/caspase-1 pathway
Wenjing Sun, Hongquan Lu, Lechun Lyu, et al.
Journal of Physiology and Biochemistry (2019) Vol. 75, Iss. 4, pp. 531-547
Closed Access | Times Cited: 61
Page 1 - Next Page

Scroll to top